RSS
13 Feb 2022

Ascletis Announces Submission of Marketing Authorization Applications for Ritonavir in Multiple European Countries

Author: admintech | Filed under: Press Release

HANGZHOU, China and SHAOXING, China, Feb. 13, 2022 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672) today announces that it has submitted marketing authorization applications for ritonavir (100 mg film-coated tablet) in Germany, France, Ireland and United Kingdom through its agent in…

This entry was posted on Sunday, February 13th, 2022 at 7:14 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»